Exclusive: U.S. Cardinal Health puts $1.5 billion China business on block – sources

HONG KONG (Reuters) – U.S. drug distributor Cardinal Health has put its China business up for sale, drawing keen interest from state-backed Chinese pharmaceutical firms in a deal that may be worth up to $1.5 billion, sources familiar with the matter said.
( read original story …)


Related Post

Hong Kong dominates Asian property investment in f...
views 31
Hong Kong attracted the most property investment i...
Will review of water deal with China make a splash...
views 37
Hong Kong may get a more favourable water import d...
Hong Kong-Zhuhai-Macau mega bridge project set to ...
views 36
Hongkongers are set to foot a ­bigger bill than ex...
Tencent links up in BOCHK pay push
views 34
BOC Hong Kong (2388), a unit of Bank of China, wil...
Hang Seng launches three ‘southbound’ Hong Kong St...
views 35
It has 275 constituents, the largest of which is T...
HSBC Private Bank fined record HK$400 million, as ...
views 49
HSBC Private Bank (Suisse) was fined a record HK$4...
Former Hong Kong home secretary turned ‘civil dipl...
views 30
A practising eye surgeon before he joined the Hong...
As Hong Kong lags behind competitors, vocational e...
views 37
Hong Kong tied for 25th place with New Zealand and...
Hong Kong Startups Win Alibaba Entrepreneurs Fund ...
views 35
Three Hong Kong-based start-ups on Tuesday each wo...
Hong Kong entrepreneurs on how to make your start-...
views 39
It is almost 6pm on a Friday and Janet Middlemiss ...